Hamming-Vrieze Olga, Balm Alfons J M, Heemsbergen Wilma D, Hooft van Huysduynen Thijs, Rasch Coen R N
Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, the Netherlands.
Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):795-800. doi: 10.1001/archoto.2009.80.
To examine the effect of adjuvant radiotherapy on regional control of melanoma neck node metastasis.
A single-institution retrospective study.
Tertiary care cancer center.
The study included 64 patients with melanoma neck node metastasis who were treated with neck dissection between 1989 and 2004 in The Netherlands Cancer Institute, Amsterdam. Twenty-four patients were treated with surgery only (15 modified radical neck dissections [MRNDs] and 9 selective neck dissections [SNDs]) (S group), and 40 patients underwent surgery (28 MRNDs and 12 SNDs) and adjuvant radiotherapy (S+RT group).
Prognostic factors, ie, number of nodes, size of nodes, and extracapsular extension, were worse in the S+RT group. With a median follow-up of 2.5 years, the 2-year ipsilateral regional recurrence (RR) rate was 18% in the S+RT group and 46% in the S group. This 28% difference in RR was not statistically significant (P = .16). However, evaluation of the effect of adjuvant RT in multivariate analysis revealed a significant reduction of the RR rate after correction for the number of involved nodes (P = .04). In the S group, SND was associated with a trend toward worse RR rate compared with MRND but was not statistically significant in univariate analysis (P = .08). The type of neck dissection did not influence the RR rate in the S+RT group (P = .60). Three of the 4 RRs occurred outside the dissected volume after SND in the S group.
Based on our findings, we conclude that, compared with extended neck dissection, SND leads to inferior regional control in patients with melanoma neck node metastasis who are not treated with RT, even those with low-risk neck disease. Furthermore, our results suggest that adjuvant RT improves regional control in patients with 2 or more involved nodes.
探讨辅助放疗对黑色素瘤颈部淋巴结转移区域控制的效果。
单机构回顾性研究。
三级癌症护理中心。
本研究纳入了1989年至2004年期间在阿姆斯特丹荷兰癌症研究所接受颈部清扫术的64例黑色素瘤颈部淋巴结转移患者。24例患者仅接受手术治疗(15例改良根治性颈部清扫术[MRND]和9例选择性颈部清扫术[SND])(S组),40例患者接受手术(28例MRND和12例SND)及辅助放疗(S+RT组)。
S+RT组的预后因素,即淋巴结数量、淋巴结大小和包膜外扩展情况较差。中位随访2.5年,S+RT组2年同侧区域复发(RR)率为18%,S组为46%。RR率的这28%差异无统计学意义(P = 0.16)。然而,多因素分析中辅助放疗效果的评估显示,在对受累淋巴结数量进行校正后RR率显著降低(P = 0.04)。在S组中,与MRND相比,SND有RR率更差的趋势,但在单因素分析中无统计学意义(P = 0.08)。颈部清扫术的类型对S+RT组的RR率无影响(P = 0.60)。S组SND后4例RR中有3例发生在清扫范围之外。
基于我们的研究结果,我们得出结论,与扩大颈部清扫术相比,对于未接受放疗的黑色素瘤颈部淋巴结转移患者,即使是低风险颈部疾病患者,SND导致的区域控制效果较差。此外,我们的结果表明,辅助放疗可改善有2个或更多受累淋巴结患者的区域控制。